SCHEMBL2386527

SCHEMBL2386527

Cc1nc(Oc2ccccc2)c(N)c(-c2ccc(C(F)(F)F)cc2F)n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.43
MPL P40238 1/20 0.41
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
HSD11B1 P28845 1/20 0.40
F10 P00742 1/20 0.38
ALOX5AP P20292 5/20 0.38
FEN1 P39748 6/20 0.38
NPSR1 Q6W5P4 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
ABCG2 Q9UNQ0 1/20 0.37
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2307176 0.92 MPL (0.41) ADORA2AMPLLMNAHSD11B1F10
SCHEMBL2388021 0.91 MPL (0.40) ADORA2AMPLLMNAHSD11B1F10
SCHEMBL2386528 0.91 L3MBTL1 (0.46) ADORA2AMPLLMNAHSD11B1ALOX5AP
SCHEMBL2388782 0.90 MPL (0.42) ADORA2AMPLLMNAHSD11B1F10
SCHEMBL2386650 0.88 MPL (0.41) ADORA2AMPLHSD11B1ALOX5APFEN1
SCHEMBL2387507 0.88 ADORA2A (0.44) ADORA2AMPLLMNAHTTF10
SCHEMBL2390925 0.84 HSD11B1 (0.43) MPLLMNAHSD11B1ALOX5APFEN1
SCHEMBL2388300 0.84 MEN1 (0.38) ADORA2AMPLHSD11B1F10ALOX5AP
SCHEMBL2387270 0.83 MPL (0.36) ADORA2AMPLHTTHSD11B1F10
SCHEMBL2390447 0.82 ALDH1A1 (0.39) ADORA2AMPLLMNAHSD11B1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230485-A1 6-PHENYL-PYRIMIDIN-4-YL-(PHENYLAMINE OR PHENOXY) DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS NEUROSEARCH A/S (DK) 2011-09-22 US claimed
US-20110230485-A1 6-PHENYL-PYRIMIDIN-4-YL-(PHENYLAMINE OR PHENOXY) DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS NEUROSEARCH A/S (DK) 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230485-A1 6-PHENYL-PYRIMIDIN-4-YL-(PHENYLAMINE OR PHENOXY) DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA5, CHRNA6, CHRNA7 ADORA2A 689/4885MPL 1319/4885LMNA 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.